by Diana Bradley
, Staff Writer | October 06, 2011
On Wednesday, the Medical Imaging & Technology Alliance, a medical equipment lobby, called on Congress to reject the Blue Cross Blue Shield Association’s proposal for Medicare to use preauthorization for advanced imaging services.
According to the BCBSA's document, "Building Tomorrow’s Healthcare System: The Pathway to High-Quality, Affordable Care in America," U.S. health care spending exceeds $2.5 trillion annually and 30 cents of every health care dollar feeds ineffective, redundant care.
In an effort to cut costs, the association has proposed a preauthorization program to ensure appropriate outpatient diagnostic imaging utilization, evidence-based clinical criteria and pertinent exchange of member information.
Midwest Hand Surgery Auction Closing 5/26 at 8PM. Hologic Fluoroscan Insight-FD Mini C-Arm, Nuvo Dual-Lamp Surgical Lighting System W/Control Panel, Ritter M11 Ultraclave Automatic Sterilizer & More! 2 Day Women's Treatment Center Auction Coming Soon!
The insurance group claims a similar program it has run since 2006 realized a gross return on investment of over 10 to one in its first two years. But MITA fears BCBSA's newly proposed procedure, also submitted to the Department of Health and Human Services, will deny physicians and patients the ability to make medical decisions -– leaving the insurance industry in charge.
"A proposal by an association of the health insurance industry to put medical decisions in the hands of the health insurance industry is simply a means to reduce access to medical imaging," David Fisher, executive director of MITA, said in a statement.
Recently, 63 percent of 2,400 American Medical Association physician survey respondents agreed prior authorization delays needed medical procedures. No peer-reviewed health economic research currently exists to prove prior authorization produces savings for Medicare, MITA said.
In addition, MITA observed that HHS noted back in 2008 that such a program would be “inconsistent with the public nature of the Medicare program,” since physician-prescribed care would be denied by private companies’ utilization of propriety systems.
"We know that these programs are highly burdensome and reduce access to care,” said Fisher.
In April, Blue Cross Blue Shield of Delaware (BCBSD) faced a backlash for its preauthorization program, when the state’s Department of Insurance discovered they were denying patients what may have been medically necessary diagnostic cardiac stress tests.
Delaware’s insurance commissioner and the U.S. Senate Committee on Commerce, Science and Transportation’s investigations found BCBSD had violated state law by signing a contract with MedSolutions, a company that denied nearly 30 percent of requests to cover nuclear stress tests, lessening costs.